Skip to main content
Log in

Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination

Studies of the relative bioavailability of verapamil tablets

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Although the absorption of verapamil is almost complete after oral administration, its bioavailability is low due to extensive hepatic first-pass metabolism. Besides large interindividual differences in first-pass metabolism, pronounced day-to-day intraindividual variations in first-pass metabolism are observed, leading to erroneous results in relative bioavailability studies. Stable isotope techniques, which permit simultaneous administration of a solution and a tablet, can successfully be used to overcome these difficulties. The method has the advantage that two experiments can be carried out in a single test. Furthermore, the number of subjects required in bioavailability studies can be greatly reduced. Using this technique the bioavailability of verapamil tablets (Isoptin® 80) relative to a stable labelled solution of verapamil was found to be 108.1%, with a 95% confidence interval between 89.1 and 127.1%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alvares AP, Kappas A, Eiseman JL, Anderson KE, Pantuck CB, Pantuck EJ, Hsiao K-C, Garland WA, Conncy AH (1979) Intraindividual variation in drug disposition. Clin Pharmacol Ther 26: 407–419

    Google Scholar 

  2. Andreasen F, Boye E, Christoffersen E, Dalsgaard P, Henneberg E, Kallenbach A, Ladefoged S, Lillquist K, Mikkelsen E, Nordero E, Olsen J, Pedersen JK, Pedersen V, Bruun Pedersen G, Schroll J, Schulz H, Seidelin J (1975) Assessment of verapamil in the treatment of angina pectoris. Eur J Cardiol 2: 443–452

    Google Scholar 

  3. Bender F (1970) Die Behandlung tachykarder Arrhythmien und der arteriellen Hypertonie mit Verapamil. Arzneim-Forsch (Drug Res) 20: 1310–1325

    Google Scholar 

  4. Daniel WW (1978) Applied nonparametric statistics, Houghton Mifflin, Boston, pp 135–139

    Google Scholar 

  5. Eichelbaum M, Ende M, Remberg G, Schomerus M, Dengler HJ (1979) The metabolism of DL-(14C)verapamil in man. Drug Metab Dispos 7: 145–148

    Google Scholar 

  6. Eichelbaum M, Somogyi A, Unruh GE von, Dengler HJ (1981) Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D, L-verapamil using stable isotope-labelled verapamil. Eur J Clin Pharmacol 19: 133–137

    Google Scholar 

  7. Fleckenstein A, Tritthart H, Fleckenstein B, Herbst A, Grün G (1969) Eine neue Gruppe kompetitiver Ca Antagonisten (Iproveratril, D 600, Prenylamin) mit starken Hemmeffekten auf die elektromechanische Koppelung im Warmblütermyokard. Pflueger's Arch ges Physiol 307: 25–32

    Google Scholar 

  8. Fleckenstein A (1972) Physiologie und Pharmakologie der transmembranären Natrium-, Kalium- und Calcium-Bewegung. Arzneim-Forsch (Drug Res) 22: 2019–2029

    Google Scholar 

  9. Heck Hd'A, Buttrill SE, Flynn NW, Dyer RL. Anbar M, Cairns T, Dighe S, Cabana BE (1979) Bioavailability of imipramine tablets relative to a stable isotope-labelled internal standard: Increasing the power of bioavailability tests. J Pharmacokinet Biopharm 7: 233–248

    Google Scholar 

  10. Kaltenbach M, Hopf R, Keller M (1976) Calciumantagonistische Therapie bei hypertroph-obstruktiver Kardiomyopathie. Dtsch Med Wochenschr 101: 1284–1287

    Google Scholar 

  11. Rosen MR, Wit AL, Hoffmann BF (1975) Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac effects of verapamil. Am Heart J 89: 665–673

    Google Scholar 

  12. Rosing DR, Kent KM, Borer JS, Seides SF, Maron BJ, Epstein SE (1979) Verapamil Therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. Circulation 60: 1201–1207

    Google Scholar 

  13. Shomerus M, Spiegelhalder B, Stieren B, Eichelbaum M (1976) Physiological disposition of verapamil in man. Cardiovasc Res 10: 605–612

    Google Scholar 

  14. Singh BN, Ellrodt G, Peter CT (1978) Verapamil: A review of its pharmacological properties and therapeutic use. Drugs 15: 169–197

    Google Scholar 

  15. Spiegelhalder B, Eichelbaum M (1977) Determination of verapamil in human plasma by mass fragmentography using stable-labelled verapamil as internal standard. Arzneim.-Forsch. 27: 94–97

    Google Scholar 

  16. Strong JM, Dutcher JS, Lee W-K, Atkinson AJ (1975) Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method. Clin Pharmacol Ther 18: 613–622

    Google Scholar 

  17. Wilkinson GR (1975) Pharmacokinetics of drug disposition: Hemodynamic considerations. Annu Rev Pharmacol 15: 11–27

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eichelbaum, M., Dengler, H.J., Somogyi, A. et al. Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Eur J Clin Pharmacol 19, 127–131 (1981). https://doi.org/10.1007/BF00568399

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00568399

Key words

Navigation